Keywords: Novo Nordisk, Hemophilia A, Turoctocog alfa, EMA, FDA, Regulatory filings

Novo Nordisk files hemophilia drug turoctocog in USA and EU

Article | 17 October 2012

Print This

Denmark’s Novo Nordisk (NOV: N), the world’s largest insulin maker, has submitted regulatory application for turoctocog ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in